cas 3222-49-9|| where to buy 5-methylpyridine-3-carboxylic acid

Название продукции:5-methylpyridine-3-carboxylic acid

IUPAC Name:5-methylpyridine-3-carboxylic acid

Упаковочная единица	Доступно для заказа	Цена ($)	Количество
CM104017-100g	in stock	ŉǵ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 3222-49-9 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:3222-49-9; Молекулярная формула:C7H7NO2; Точка плавления:-; Smiles-код:CC1=CC(=CN=C1)C(O)=O; Плотность:

: Номер в каталоге:CM104017; Молекулярная масса:137.14; Точка кипения:303.9°C at 760 mmHg; Номер Mdl:MFCD00829036; Хранение:Keep in inert atmosphere, store at room temperature.

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Seralutinib; Gossamer Bio and Chiesi Farmaceutici announced that they have entered into a global collaboration and license agreement to develop and commercialize seralutinib. Seralutinib is an inhaled PDGFRα/β, CSF1R, and c-KIT inhibitor designed to be delivered via dry powder inhaler for the potential treatment of pulmonary hypertension.